Amitriptyline for major depression
29 results
1 - 29
Amitriptyline for major depression 
Amitriptyline versus placebo for major depressive disorder: Cochrane systematic review- Pharmacological treatment of depression
- Antipsychotics for fibromyalgia in adults
- Antidepressants for depression in Parkinson's disease
- Therapies for depression in Parkinson's disease: Cochrane systematic review
- Antidepressants for pain management in adults with chronic pain: a network meta‐analysis
- Fluvoxamine versus other anti‐depressive agents for depression
- Paroxetine versus other anti-depressive agents for depression
- Sertraline versus other antidepressive agents for depression
- Antidepressants for chronic non‐cancer pain in children and adolescents
- Fluoxetine versus other types of pharmacotherapy for depression
- Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults
- Antidepressants for the treatment of people with co-occurring depression and alcohol dependence: Cochrane systematic review
- Imipramine for neuropathic pain in adults
- Desipramine for neuropathic pain in adults
- Mirtazapine for fibromyalgia in adults
- Fluoxetine versus other types of pharmacotherapy for depression
- Paroxetine versus other anti-depressive agents for depression: Cochrane systematic review
- Antiepileptic drugs for chronic non‐cancer pain in children and adolescents
- Anticonvulsants for fibromyalgia: Cochrane systematic review
- Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
- Cognitive behavioural therapies for fibromyalgia